Loupe-Based Intraoperative Fluorescence Imaging
Launched by GUOQIANG YU · Feb 26, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new wearable device that uses special imaging technology to help surgeons see brain tumors more clearly during surgery. The main goal is to see if this smaller, easier-to-use device can accurately identify tumor tissues, just like the larger, more complex microscope that is usually used. The researchers hope that this new device will make it easier and safer for doctors to remove as much of the tumor as possible, which can improve survival for patients with glioblastoma multiforme and anaplastic astrocytoma, two types of serious brain tumors.
To participate in this study, individuals must be adults aged 18 and older who have been diagnosed with a malignant brain tumor and are scheduled for surgery to have it removed. Unfortunately, pregnant women, those under 18, patients needing emergency surgery, or anyone unable to give consent due to communication difficulties cannot join. Participants can expect to have their surgery with the new device and then have their tumor tissues examined afterward to see how well the device worked. This trial is currently looking for volunteers to help advance this promising technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults with brain malignant gliomas undergoing resection
- • at least 18 years of age
- • able to understand the consent
- Exclusion Criteria:
- • pregnant women
- • under 18 years of age
- • patients undergoing emergency surgery
- • inability to give consent due to dysphagia or language barrier
About Guoqiang Yu
Guoqiang Yu is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a focus on rigorous scientific methodology and ethical standards, Guoqiang Yu oversees the design, implementation, and management of clinical trials across various therapeutic areas. By fostering collaboration among researchers, healthcare professionals, and regulatory bodies, Guoqiang Yu aims to accelerate the development of new therapies and enhance the understanding of complex health conditions, ultimately contributing to the advancement of healthcare and patient well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Patients applied
Trial Officials
Guoqiang Yu, PhD
Principal Investigator
University of Kentucky
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials